Visterra Inc.
Brian Pereira serves as a Board Member for ProKidney Corp., Africa Healthcare Network, and the American India Foundation, and holds the position of Chairman of the Board at KalVista Pharmaceuticals, Inc. Additionally, Brian Pereira is President & CEO of Visterra Inc. and previously held roles as Executive Chairman at Abeona Therapeutics and Chairman of the Board at NephroPlus and Cullinan Oncology Pearl. Prior positions include President & CEO of AMAG Pharmaceuticals, Inc., and President & CEO of Tufts Medical Center Physician Organization. Brian Pereira completed an MBA at Northwestern University's Kellogg School of Management, a Nephrology Research Fellowship at Tufts Medical Center, and multiple medical degrees from Post Graduate Institute of Medical Education & Research and St. Johns Medical College.
Visterra Inc.
1 followers
Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. andchanged its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.